Work

Multimodal habitat radiomics based on automated breast volume scanning and conventional ultrasound for risk stratification of biopsy-confirmed BI-RADS 4A breast lesions

Year: 2026

Type: article

Abstract: Background: To develop and validate a multimodal habitat radiomics model integrating automated breast volume scanning (ABVS) and conventional two-dimensional ultrasound (2D-US) for risk stratification of biopsy-selected BI-RADS 4A breast lesions. Methods: This retrospective single-center study included 160 consecutive patients with BI-RADS 4A breast lesions confirmed by histopathology between January 2024 and May 2025. Tumoral and peritumoral regions were manually segmented on ABVS and 2D-US images. Habitat subregions were generated using a local spatial autocorrelation-based heterogeneity analysis. Radiomic features were extracted using PyRadiomics. Feature selection was performed using t-test filtering, Pearson correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression within the training folds. Multiple machine learning classifiers were constructed using three-fold cross-validation. Model performance was evaluated using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1 score, calibration curves, and decision curve analysis (DCA). Results: Of the 160 lesions, 51 (31.9%) were malignant and 109 (68.1%) were benign. The habitat radiomics model outperformed the clinical-ultrasound model. The optimal multilayer perceptron classifier achieved an AUC of 0.910 and an accuracy of 0.869 in the validation cohort. Decision curve analysis demonstrated higher net benefit across a range of threshold probabilities, and calibration curves indicated good agreement between predicted and observed outcomes. Conclusion: Multimodal habitat radiomics integrating ABVS and conventional ultrasound demonstrated promising performance for risk stratification of biopsy-selected BI-RADS 4A lesions and may provide supportive information for individualized clinical decision-making. Further prospective multicenter validation is warranted before clinical application.

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2026.1828818

Authors: Fei Xia, Yu Zhang, Banghong Qiang, Junli Wang

Institution: East China Normal University

Language: English

Topic: Radiomics and Machine Learning in Medical Imaging

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801